EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma.
Blomquist MR, Eghlimi R, Beniwal A, Grief D, Nascari DG, Inge L, Sereduk CP, Tuncali S, Roos A, Inforzato H, Sharma R, Pirrotte P, Mehta S, Fortin Ensign SP, Loftus JC, Tran NL.
Blomquist MR, et al. Among authors: tuncali s.
Int J Mol Sci. 2024 Jun 6;25(11):6279. doi: 10.3390/ijms25116279.
Int J Mol Sci. 2024.
PMID: 38892466
Free PMC article.